Researchers say new research findings might point to a major opportunity to act sooner to prevent rheumatoid arthritis.

The most important takeaway from the study is that these data suggest that CD47 is an attractive target for drug development.

A trio of stock analysts this week examined the likely impacts on biopharma from Donald Trump’s election victory and ...

Researchers say study offers proof-of-concept that targeting how T cells interact with metabolites in their environment can ...

Julianna LeMieux and Uduak Thomas discuss their time at the ASHG meeting in Denver and some of the trends that they are ...

New research demonstrates how a chemical produced by a caterpillar fungus shows promise as a possible cancer treatment by ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

ProBioGen’s AGE1.CR.PIX been developed as a stable proliferating avian cell line that is highly permissive for different ...

Lonza has continued to adapt to the evolving ADC landscape, including the recent addition of a highly potent vial fill ...

PacBio launches the Vega System: a new sequencing platform that brings the company's HiFi sequencing technology to the ...

DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.

Customers will also share data from studies using the technologies including an effort to investigate protein biomarkers for ...